The microbiota–gut–brain axis (MGBA) allows bidirectional crosstalk between the brain and gut microbiota (GM) and is believed to contribute to regulating mood/cognition/behaviour/metabolism/health and homeostasis. Manipulation of GM through faecal microbiota transplant (FMT) is a new, exciting and promising treatment for major depressive disorder (MDD).
Aims:
This mini-review examines current research into GM and FMT as a therapy for depression.
Methods:
Original research articles published in Medline/Cochrane Library/PubMed/EMBASE/PsycINFO databases/National Institute of Health website Clinicaltrials.gov/controlled-trials.com were searched. Full articles included in reference lists were evaluated. We summarise current data on GM and depression and discuss communication through the MGBA and the interaction of antidepressants and GM through this. We review compositions of dysbiosis in depressed cohorts, focusing on future directions in the treatment of MDD.
Results:
Studies have demonstrated significant gut dysbiosis in depressed patients compared to healthy cohorts, with overgrowth of pro-inflammatory microbiota, reduction in anti-inflammatory species and reduced overall stability and taxonomic richness. FMT allows the introduction of healthy microbiota into the gastrointestinal tract, facilitating the restoration of eubiosis.
Conclusion:
The GM plays an integral role in human health and disease through its communication with the rest of the body via the MGBA. FMT may provide a means to transfer the healthy phenotype into the recipient and this concept in humans is attracting enormous attention as a prospective treatment for psychopathologies, such as MDD, in the future. It may be possible to manipulate the GM in a number of ways, but further research is needed to determine the exact likelihood and profiles involved in the development and amelioration of MDD in humans, as well as the long-term effects and potential risks of this procedure.
AlliSRGorbovskayaILiuJC, et al. (2022) The gut microbiome in depression and potential benefit of prebiotics, probiotics and synbiotics: A systematic review of clinical trials and observational studies. Int J Mol Sci23: 4494.
4.
BercikPDenouECollinsJ, et al. (2011) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology141: 599–609.e3.
5.
BhattSKanoujiaJMohana LakshmiS, et al. (2023) Role of brain-gut-Microbiota axis in depression: Emerging therapeutic avenues. CNS & Neurol Disord – Drug Targets22: 276–288. Available at: http://www.eurekaselect.com/article/121982 (accessed 15 January 2024).
6.
BorodyTJWarrenEFLeisSM, et al. (2004) Bacteriotherapy using fecal flora: Toying with human motions. J Clin Gastroenterol38: 475–483.
7.
Borrego-RuizABorregoJJ (2024) An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders. Progr Neuro-Psychopharmacol Biol Psychiatry128: 110861.
8.
Bruce-KellerAJSalbaumJMLuoM, et al. (2015) Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry77: 607–615.
9.
CaiTShiXYuanLZ, et al. (2019) Fecal microbiota transplantation in an elderly patient with mental depression. Int Psychogeriatrics31: 1525–1526.
ChenXMengSYuY, et al. (2022) The role of probiotic intervention in regulating gut microbiota, short-chain fatty acids and depression-like behavior in lead-exposed rats. Int J Occup Med Environ Health35: 95–106.
12.
Chinna MeyyappanAForthEWallaceCJ, et al. (2020) Effect of fecal microbiota transplant on symptoms of psychiatric disorders: A systematic review. BMC Psychiatry20: 1–9.
13.
ChinnaMForthEMilevR (2022) Microbial ecosystem therapeutic-2 intervention in people with major depressive disorder and Generalized Anxiety Disorder: Phase 1, open-label study. Interact J Med Res11: e32234.
14.
ClarkeGGrenhamSScullyP, et al. (2013) The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry18: 666–673.
CussottoSStrainCRFouhyF, et al. (2019) Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology236: 1671–1685.
17.
DollJPVázquez-CastellanosJFSchaubAC, et al. (2022) Fecal Microbiota Transplantation (FMT) as an adjunctive therapy for depression – Case report. Front Psychiatry13: 815422.
FontanaAManchiaMPanebiancoC, et al. (2020) Exploring the role of gut Microbiota in major depressive disorder and in treatment resistance to antidepressants. Biomedicines8: 311.
20.
FriesGRSaldanaVAFinnsteinJ, et al. (2022). Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry28: 284–297.
21.
GaoKFarziAKeX, et al. (2022) Oral administration of Lactococcus lactis WHH2078 alleviates depressive and anxiety symptoms in mice with induced chronic stress. Food Funct13: 957–969.
22.
GreenJEBerkMMohebbiM, et al. (2023) Feasibility, acceptability, and safety of faecal Microbiota transplantation in the treatment of major depressive disorder: A pilot randomized controlled trial. Can J Psychiatry. Revue canadienne de psychiatrie68: 315–326.
23.
HintonR. (2020) A case report looking at the effects of faecal microbiota transplantation in a patient with bipolar disorder. Aust N Z J Psychiatry4: 649–650.
24.
HouKWuZXChenXY, et al. (2022) Microbiota in health and diseases. Sign Trans Targeted Ther7: 135.
25.
HuangCYangXZengB, et al. (2019) Proteomic analysis of olfactory bulb suggests CACNA1E as a promoter of CREB signaling in microbiota-induced depression. J Proteomics194: 132–147.
26.
HuangSHuSLiuS, et al. (2022) Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner. Pharmacol Res175: 105992.
27.
JangHMKimJKJooMK, et al. (2021) Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice. Sci Rep11: 1–13.
28.
KangDWAdamsJBGregoryAC, et al. (2017) Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome5: 1–16.
29.
KellyJRBorreYO’BrienC, et al. (2016) Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatric Res82: 109–118.
30.
KirschI (2019) Placebo effect in the treatment of depression and anxiety. Front Psychiatry10: 407.
31.
KnudsenJKMichaelsenTYBundgaard-NielsenC, et al. (2021) Faecal microbiota transplantation from patients with depression or healthy individuals into rats modulates mood-related behaviour. Sci Rep11: 21869.
32.
KoppenolETerveerEMVendrikKE, et al. (2022) Fecal microbiota transplantation is associated with improved aspects of mental health of patients with recurrent Clostridioides difficile infections. J Affect Disord Rep9: 100355.
33.
KuijerEJSteenbergenL (2023) The microbiota-gut-brain axis in hippocampus-dependent learning and memory: Current state and future challenges. Neurosci Biobehav Rev152: 105296.
34.
KurokawaSKishimotoTMizunoS, et al. (2018) The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study. J Affect Disord235: 506–512.
35.
LiuLWangHChenX, et al. (2023) Gut microbiota and its metabolites in depression: From pathogenesis to treatment. EBioMedicine90: 104527.
36.
LiuRTRowan-NashADSheehanAE, et al. (2020a) Reductions in anti-inflammatory gut bacteria are associated with depression in a sample of young adults. Brain Behav Immunity88: 308–324.
37.
LiuSGuoRLiuF, et al. (2020b) Gut Microbiota regulates depression-like behavior in rats through the neuroendocrine-immune-mitochondrial pathway. Neuropsych Dis Treat16: 859–869.
38.
LukićIGetselterDZivO, et al. (2019) Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry9: 1–16.
39.
MarinIAGoertzJERenT, et al. (2017) Microbiota alteration is associated with the development of stress-induced despair behavior. Sci Rep7: 1–10.
40.
MayerEANanceKChenS (2022) The gut–brain axis. Ann Rev Med73: 439–453.
41.
McGuinnessAJDavisJADawsonSL, et al. (2022) A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry27: 1920–1935.
MengYSunJZhangG (2023) Pick fecal microbiota transplantation to enhance therapy for major depressive disorder. Progr Neuro-Psychopharmacol Biol Psychiatry128: 110860.
44.
MoncrieffJCooperREStockmannT, et al. (2023) The serotonin theory of depression: A systematic umbrella review of the evidence. Mol Psychiatry28: 3243–3256.
45.
MoraisLHSchreiberHLMazmanianSK (2021) The gut microbiota–brain axis in behaviour and brain disorders. Nat Rev Microbiol19: 241–255.
46.
Munoz-BellidoJLMunoz-CriadoSGarcı̀a-Rodrı̀guezJA (2000) Antimicrobial activity of psychotropic drugs. Int J Antimicrobial Agents14: 177–180.
47.
NikolovaVLSmithMRHallLJ, et al. (2021) Perturbations in gut Microbiota composition in psychiatric disorders: A review and meta-analysis. JAMA Psychiatry (Chicago, Ill.)78: 1343.
48.
ParkerGSpoelmaMJRhodesN (2022) Faecal microbiota transplantation for bipolar disorder: A detailed case study. Bipolar Disord24: 559–563.
49.
PitzerCKurpiersBEltokhiA (2022) Sex differences in depression-like behaviors in adult mice depend on endophenotype and strain. Front Behav Neurosci16: 838122.
50.
PouranayatihosseinabadMBezabihYHawrelakJ, et al. (2023) Antibiotic use and the development of depression: A systematic review. J Psychosomatic Res164: 111113.
51.
RaoJQiaoYXieR, et al. (2021) Fecal microbiota transplantation ameliorates stress-induced depression-like behaviors associated with the inhibition of glial and NLRP3 inflammasome in rat brain. J Psychiatr Res137: 147–157.
52.
RutschAKantsjöJBRonchiF (2020) The gut-brain axis: How Microbiota and host inflammasome influence brain physiology and pathology. Front Immunol11: 604179.
53.
ShenYYangXLiG, et al. (2021) The change of gut microbiota in MDD patients under SSRIs treatment. Sci Rep11: 14918.
54.
SiopiEChevalierGKatsimpardiL, et al. (2020) Changes in gut Microbiota by chronic stress impair the efficacy of fluoxetine. Cell Rep30: 3682–3690.
55.
SunLZhangHCaoY, et al. (2019) Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice. Int J Med Sci16: 1260–1270.
56.
TaoYZhouHLiZ, et al. (2024) TGR5 deficiency-induced anxiety and depression-like behaviors: The role of gut microbiota dysbiosis. J Affect Disord344: 219–232.
57.
TurnbaughPJLeyREMahowaldMA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature444: 1027–1031.
58.
Valles-ColomerMFalonyGDarziY, et al. (2019) The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol4: 623–632.
59.
Van de WouwMBoehmeMLyteJM, et al. (2018) Short-chain fatty acids: Microbial metabolites that alleviate stress-induced brain–gut axis alterations. J Physiol596: 4923–4944.
60.
VaresiACampagnoliLIChirumboloS, et al. (2023) The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches. Pharmacol Res192: 106799.
61.
VindegaardNSpeyerHNordentoftM, et al. (2021) Gut microbial changes of patients with psychotic and affective disorders: A systematic review. Schizophrenia Res234: 41–50.
62.
WangSIshimaTZhangJ, et al. (2020a) Ingestion of Lactobacillus intestinalis and Lactobacillus reuteri causes depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve. J Neuroinflamm17: 1–12.
63.
WangYXuXLuoA, et al. (2020b) The role of gut Microbiota in the antidepressant effects of ketamine. In: Ketamine. Singapore: Springer Singapore, pp. 127–141.
XieWRYangXYXiaHH, et al. (2019) Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: A case report and review of the literature. World J Clin Cases7: 3074–3081.
66.
YangCHuTSuX, et al. (2023) Multi-omics analysis of fecal microbiota transplantation’s impact on functional constipation and comorbid depression and anxiety. BMC Microbiol23: 389.
67.
YooJWShinYJMaX, et al. (2022) The alleviation of gut Microbiota-induced depression and colitis in mice by anti-inflammatory probiotics NK151, NK173, and NK175. Nutrients14: 2080.
68.
YunSWKimJKLeeKE, et al. (2020) A probiotic Lactobacillus gasseri alleviates Escherichia coli-induced cognitive impairment and depression in mice by regulating IL-1β expression and gut Microbiota. Nutrients12: 3441.
69.
ZhengPZengBLiuM, et al. (2019) The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv5: eaau8317.
70.
ZhengPZengBZhouC, et al. (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry21: 786–796.
